This photo taken taken Monday Nov.30, 2020 shows the logo of French drug maker Sanofi at the company's headquarters, in Paris. Drugmakers GlaxoSmithKline and Sanofi say their potential COVID-19 vaccine won't be ready until late next year as they seek to improve the shot's effectiveness in older people. The companies said Friday that early-stage trials showed the vaccine produced an "insufficient" immune response in older adults, demonstrating the need to refine the product so it protects people of all ages (AP Photo/Thibault Camus)
Follow @bleonardcns
Categories /
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
